Article ISI SCOPUS
BMC PEDIATRICS  (2010)

A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season

Fernández P.; Trenholme, A; Abarca K.; Griffin, MP; Hultquist, M; Harris B.; Losonsky, GA

Más información

Título según WOS: A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season
Título según SCOPUS: A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season
Título de la Revista: BMC PEDIATRICS
Volumen: 10
Editorial: BIOMED CENTRAL LTD
Fecha de publicación: 2010
Idioma: English
URL: http://www.biomedcentral.com/1471-2431/10/38
DOI:

10.1186/1471-2431-10-38
Notas: ISI, SCOPUS